GLPro Official Website › Blog › Blood sugar supplement ingredients
The Ingredients Most Blood Sugar Supplements Use, And The Evidence
Five ingredient families turn up in blood sugar formulas again and again. What the pooled trials found for each, at what doses, and with what limits. GLPro does not say whether it contains any of them.
- GLPro publishes no ingredient list. Nothing here describes what is in GLPro. It describes the category.
- Berberine has the most trial data, mostly from small studies, and it affects how some drugs are cleared.
- Cinnamon and chromium are mixed. Pooled results point in different directions, and products vary.
- Gymnema’s trials are few and small. Psyllium fibre has steadier results, at gram doses no capsule holds.
General information, not medical advice. GLPro is a dietary supplement for healthy adults aged 18 and over. It is not a drug, not a GLP-1 medication and not FDA-approved, and it is not a treatment for diabetes, prediabetes or any other condition. Blood sugar is a medical matter: if you have a diagnosis or take any prescribed medicine, talk to your clinician or pharmacist before adding anything, and never change a prescribed dose on your own. Low blood sugar is urgent. Shakiness, sweating, confusion or a racing heart in someone who takes diabetes medicine needs treating at once, and if the person cannot swallow or does not improve, call 911.
How to read this article
Look up almost any blood sugar supplement and the same few ingredient names come back. This article takes the five most common families in turn: what the research found, at what dose, and where it runs out.
First, the sentence this article keeps repeating: GLPro does not say whether it contains any of these ingredients. The seller describes the formula only as a proprietary blend of natural ingredients. This desk holds no ingredient list, so it names none, estimates none and hints at none. The ingredients page explains the gap in full.
Read what follows as a guide to the shelf, useful for comparing products that do publish their formulas and for knowing what to ask about one that does not.
Berberine
Berberine is a bitter yellow compound found in several plants, goldenseal and barberry among them. It has the largest body of trials in this category, most of them run in China.
What the meta-analyses found
Dong and colleagues, in 2012, pooled randomised trials in people with type 2 diabetes and reported lower fasting glucose, post-meal glucose and A1C with berberine than with lifestyle change or placebo alone. Guo and colleagues, in 2021, pooled a later set of randomised trials and reported improvements in glucose measures and in blood fats. Doses commonly ran from about 0.5 to 1.5 grams a day, split across two or three servings.
The limits
Most trials were small and short, many were not blinded, and the studies pooled were of mixed quality. They enrolled people with type 2 diabetes, often alongside their medicines, which is not the same group as a healthy adult buying a supplement.
Safety
Berberine slows several of the liver enzymes that clear prescription drugs, can upset the stomach, and is not advised in pregnancy or breastfeeding. It is the ingredient here most likely to matter to someone on medicine, and our article on diabetes medicines sets out the evidence.
In GLPro: not published. The seller does not say whether it is in the capsule.
Cinnamon
Cinnamon supplements are usually made from cassia, the common supermarket kind, or from Ceylon cinnamon. The interest comes from laboratory work suggesting cinnamon compounds affect how cells respond to insulin.
Allen and colleagues’ 2013 meta-analysis pooled ten randomised trials in type 2 diabetes, with doses from 120 milligrams to 6 grams a day for 4 to 18 weeks. It found a statistically significant fall in fasting glucose and no significant change in A1C, and the trials differed so much that the size of the fasting figure is hard to rely on.
Costello and colleagues’ 2016 review came at the same question with an eye on product quality, concluded that the evidence did not support a clear role for cinnamon supplements in blood sugar control, and pointed to how much products differ. NCCIH lands in a similar place and adds a safety point: cassia contains coumarin, which in large amounts can harm the liver in sensitive people.
- Doses studied: 120 mg to 6 g a day.
- Best-supported finding: a fasting glucose change, with wide variation between trials.
- A1C: no significant change in the pooled data.
- In GLPro: not published. The seller does not say whether it is in the capsule.
Chromium
Chromium is a trace mineral that the body needs in micrograms. The adequate intake, set by the Food and Nutrition Board and reported by the NIH Office of Dietary Supplements, is 25 to 35 micrograms a day for most adults under 51, and chromium turns up in blood sugar formulas because of a long-standing idea that it helps insulin work.
Suksomboon and colleagues’ 2014 meta-analysis pooled trials in people with diabetes and reported modest improvements in some glucose measures, with results that differed by the form of chromium used, and no clear difference in side effects against placebo. The NIH fact sheet describes the research overall as mixed and notes that chromium supplements can interact with some medicines, including those for diabetes.
Trial doses were usually in the hundreds of micrograms a day, many times the adequate intake, so a label that says chromium without a number tells you nothing about which it is.
- Doses studied: usually hundreds of micrograms a day.
- Best-supported finding: modest effects on some glucose measures, varying by form.
- Main limit: mixed results across analyses.
- In GLPro: not published. The seller does not say whether it is in the capsule.
GLPro: a daily capsule with no published formula
Thirty capsules a bottle, sold to support blood sugar and appetite control. The seller does not say which ingredients are inside, and this desk prints that on every page instead of guessing.
$49 to $79 a bottle · 60-day money-back guarantee
Order GLPro
Gymnema
Gymnema sylvestre is a climbing plant used in Ayurvedic practice. Its leaves contain gymnemic acids, which briefly blunt the taste of sweetness when chewed, and that effect is the root of its reputation with sugar cravings.
Devangan and colleagues’ 2021 meta-analysis pooled randomised trials in type 2 diabetes and reported reductions in fasting glucose, post-meal glucose and A1C. It also set out what limits those findings: the trials were few, mostly small, and used different extracts at different doses.
- Doses studied: varied by extract, with no common standard across trials.
- Best-supported finding: glucose reductions in a small set of trials.
- Main limit: few trials, small samples, different extracts.
- In GLPro: not published. The seller does not say whether it is in the capsule.
The sweet-taste effect is real in the mouth and short-lived, which is not the same as an effect on appetite across a day. Our article on appetite claims explains the difference.
Soluble fibre
Soluble fibres such as psyllium form a gel in the gut that slows how quickly carbohydrate is absorbed. Unlike the botanicals above, fibre is food, and the evidence for it is steadier.
Gibb and colleagues’ 2015 meta-analysis pooled trials of psyllium and found that it improved fasting glucose and A1C in people with type 2 diabetes and in people at risk of it. The effect grew with how raised glucose was to begin with, and was negligible in people whose glucose was normal. Doses were measured in grams, commonly around 10 grams a day spread across the day.
That dose is the catch for any capsule. A standard capsule holds well under a gram, so several grams of fibre means a spoonful of powder stirred into water. A capsule can list a fibre, but it cannot hold a trial dose of one.
- Doses studied: grams a day, commonly around 10 g.
- Best-supported finding: glucose improvements in proportion to how raised glucose was.
- Main limit: the dose does not fit in a capsule.
- In GLPro: not published. The seller does not say whether it is in the capsule.
The five, side by side
| Ingredient | Doses studied | What pooled trials found | Main limit | In GLPro? |
|---|---|---|---|---|
| Berberine | About 0.5 to 1.5 g a day | Lower fasting glucose and A1C in type 2 diabetes | Small trials; slows drug-clearing enzymes | Not published |
| Cinnamon | 120 mg to 6 g a day | A fasting glucose change; no clear A1C change | Wide variation between trials and products | Not published |
| Chromium | Hundreds of mcg a day | Modest effects on some measures | Mixed results; form matters | Not published |
| Gymnema | Varied by extract | Glucose reductions in a few trials | Few, small, unstandardised trials | Not published |
| Psyllium fibre | Around 10 g a day | Improvements that grew with starting glucose | Gram doses, not capsule doses | Not published |
The trials behind this table mostly studied people with type 2 diabetes or raised glucose (the psyllium analysis also pooled people with normal glucose), each using a named ingredient at a stated dose. None studied GLPro.
The pattern is consistent. The botanicals have small trial records and wide variation, fibre has steadier evidence at doses no capsule holds, and every row is only useful if it can be matched to a label by name and amount.
What a label must print before any of this applies
If a blood sugar supplement wants a reader to connect it to any of this research, its label has to print a few things. None of them is unusual, and many products on the shelf print all of them.
- Each ingredient by name, including the plant part or the chemical form.
- The amount of each, not only a blend total.
- The serving the amounts refer to, so one capsule and two are not confused.
- Other ingredients, including the capsule shell.
- A standardisation figure for botanical extracts, where one exists.
GLPro publishes none of these online. A Supplement Facts panel is required on the physical bottle, so a buyer holding one can read it. Until the seller publishes it, every row of the table above ends in not published. The label page lists every blank, and our guide to choosing a blood sugar supplement turns these points into a checklist.
The verdict
Five ingredient families dominate blood sugar formulas. Berberine has the most trials and the most important interaction warning. Cinnamon and chromium have pooled results that point in different directions. Gymnema has a thin record. Soluble fibre has the steadiest evidence and the least portable dose.
None of that is evidence about GLPro, which does not say whether it contains any of the five. A buyer is weighing a daily capsule with two label claims, an unpublished formula and a 60-day guarantee. The pricing page and the reviews page set out the rest, and if the seller ever publishes a formula, this article changes first.
Sources cited in this article
- Dong H, Wang N, Zhao L, Lu F. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evid Based Complement Alternat Med. 2012;2012:591654. https://pubmed.ncbi.nlm.nih.gov/23118793/
- Guo J, Chen H, Zhang X, et al. The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Oxid Med Cell Longev. 2021;2021:2074610. https://pubmed.ncbi.nlm.nih.gov/34956436/
- Allen RW, Schwartzman E, Baker WL, Coleman CI, Phung OJ. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med. 2013;11(5):452-9. https://pubmed.ncbi.nlm.nih.gov/24019277/
- Costello RB, Dwyer JT, Saldanha L, et al. Do Cinnamon Supplements Have a Role in Glycemic Control in Type 2 Diabetes? A Narrative Review. J Acad Nutr Diet. 2016;116(11):1794-1802. https://pubmed.ncbi.nlm.nih.gov/27618575/
- National Center for Complementary and Integrative Health. Cinnamon: Usefulness and Safety. https://www.nccih.nih.gov/health/cinnamon
- Suksomboon N, Poolsup N, Yuwanakorn A. Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes. J Clin Pharm Ther. 2014;39(3):292-306. https://pubmed.ncbi.nlm.nih.gov/24635480/
- NIH Office of Dietary Supplements. Chromium: Fact Sheet for Consumers. https://ods.od.nih.gov/factsheets/Chromium-Consumer/
- Devangan S, Varghese B, Johny E, et al. The effect of Gymnema sylvestre supplementation on glycemic control in type 2 diabetes patients: A systematic review and meta-analysis. Phytother Res. 2021;35(12):6802-6812. https://pubmed.ncbi.nlm.nih.gov/34467577/
- Gibb RD, McRorie JW Jr, Russell DA, Hasselblad V, D'Alessio DA. Psyllium fiber improves glycemic control proportional to loss of glycemic control: a meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being treated for type 2 diabetes mellitus. Am J Clin Nutr. 2015;102(6):1604-14. https://pubmed.ncbi.nlm.nih.gov/26561625/